Theriva Biologics, Inc. (TOVX) earnings
TOVX earnings moved a median of +0.68% by the close. Quarterly and annual TOVX reports and results, each read against the price at its own news timestamp. Back to the TOVX overview →
12 measured TOVX earnings events.
Where these TOVX earnings landedvs 12 measured TOVX earnings reactions
| Middle 50% of TOVX earnings reactions | -1.71% to +3.39% |
|---|---|
| Median reaction (to close) | +0.68% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 TOVX earnings events with a measured close landed between -1.71% and +3.39%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Theriva Biologics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.63% | +2.63% | |
| Form 10-Q Theriva Biologics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +5.14% | +9.14% | |
| Form 10-K Theriva Biologics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.22% | +1.12% | |
| Form 10-Q Theriva Biologics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.45% | +2.76% | |
| Form 10-Q Theriva Biologics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.73% | +14.88% | |
| Form 10-Q Theriva Biologics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.88% | -1.36% | |
| Form 10-K Theriva Biologics, Inc. For: Dec 31 | SEC filing · Form 10-K | +5.36% | -1.45% | |
| Form 10-Q Theriva Biologics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.46% | -11.73% | |
| Form 10-Q Theriva Biologics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -5.06% | -2.50% | |
| Form 10-Q Theriva Biologics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +5.29% | |
| Form 10-K Theriva Biologics, Inc. For: Dec 31 | SEC filing · Form 10-K | -7.92% | -9.25% | |
| Form 10-Q Theriva Biologics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +5.26% | +0.25% |
Keep exploring
More TOVX: analyst actions → · SEC filings → · TOVX overview →